Despite the progress made in the management of lung adenocarcinoma (LUAD), the overall
prognosis for LUAD individuals remains suboptimal. While the role of cell polarity in tumor …

Background. Lung adenocarcinoma is the most common lung cancer subtype and accounts
for the highest proportion of cancer‐related deaths. The tumor microenvironment influences …

Background Lung adenocarcinoma (LUAD) is a group of cancers with poor prognosis. The
combination of single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing (RNA …

Background The pathogenesis and clinical diagnosis of lung adenocarcinoma (LUAD), a
malignant illness with substantial morbidity and mortality, are still being investigated. Genes …

Background. Epigenetic modifications have been revealed to play an important role in
tumorigenesis and tumor development. This study aims to analyze the role of histone …

Purpose Lung adenocarcinoma (LUAD) is the predominant subtype of lung cancer, with
increasing evidence showing clinical benefits of immunotherapy. However, a lack of …

Background Lung adenocarcinoma (LUAD) has a complex tumor heterogeneity. Our
research attempts to clearness LUAD subtypes and build a reliable prognostic signature …

Traditional pathological diagnoses and clinical methods are insufficient to accurately predict
the prognosis of lung adenocarcinoma (LUAD). Epithelial-mesenchymal transition (EMT) …

Lung adenocarcinoma (LUAD), the most common non‐small‐cell lung cancer, is
characterized by a dense lymphocytic infiltrate, which indicates that the immune system …

Objective: Lung adenocarcinoma (LUAD) is a highly heterogeneous tumor. Tumor mutations
and the immune microenvironment play important roles in LUAD development and …